Rebecca Velez Frey

Rebecca Velez Frey

No más puestos en curso
52 años
Health Technology
Finance
Consumer Services

Perfil

Rebecca Velez Frey is currently President, Chief Executive Officer & Director and President & Chief Executive Officer at Yarrow Bioscience, Inc. since 2025.
Also holds positions on the Board of Directors at Halda Therapeutics LLC, Director at Siduma Therapeutics, Inc. since 2021, and Venture Partner at RTW Investments LP since 2025.
Formerly Associate Director at Novartis Inflammasome Research, Inc. from 2002 to 2006, Vice President at Alexion Pharmaceuticals, Inc. from 2012 to 2017, Chief Operating Officer at Cardurion Pharmaceuticals, Inc. from 2018 to 2020, Chief Operating Officer at Evolveimmune Therapeutics, Inc. from 2020 to 2021, and Venture Partner at Elm Street Advisors LLC from 2021 to 2025.
Earned a doctorate from Northeastern University in 1998.

Cargos activos de Rebecca Velez Frey

EmpresasCargoInicio
Director/Miembro de la Junta -
Director/Miembro de la Junta 01/12/2021
Inversor de Capital Privado 01/02/2025

Antiguos cargos conocidos de Rebecca Velez Frey.

EmpresasCargoFin
Inversor de Capital Privado 01/12/2025
Director de Operaciones 31/12/2021
Director de Operaciones 31/12/2020
ALEXION PHARMACEUTICALS, INC. Presidente 30/09/2017
Director/Miembro de la Junta 30/09/2006
Ver el detalle de la experiencia de Rebecca Velez Frey.

Formación de Rebecca Velez Frey.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

88

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

  1. Bolsa de valores
  2. Insiders
  3. Rebecca Velez Frey